• OPEN AN ACCOUNT
Indian Indices
Nifty
22,475.85 -172.35
(-0.76%)
Sensex
73,878.15 -732.96
( -0.98%)
Bank Nifty
48,923.55 -307.50
( -0.62%)
Nifty IT
32,908.40 -294.95
( -0.89%)
Global Indices
Nasdaq
16,156.33 315.37
(1.99%)
Dow Jones
38,675.68 450.02
(1.18%)
Hang Seng
18,475.92 268.79
(1.48%)
Nikkei 225
38,236.07 -37.98
(-0.10%)
Forex
USD-INR
83.43 -0.03
(-0.04%)
EUR-INR
89.37 0.26
(0.29%)
GBP-INR
104.48 0.21
(0.20%)
JPY-INR
0.54 0.01
(1.69%)

EQUITY - MARKET SCREENER

Dr Reddys Laboratories Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
500124
INE089A01023
1361.8538112
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
DRREDDY
26.62
105928.76
EPS(TTM)
Face Value()
Div & Yield %
238.56
5
0.63
 

Dr Reddys Laboratories Ltd
Dr. Reddy's launches condition management programme DailyBloom™ IBS
Apr 19,2024
Dr. Reddy's Laboratories announced the roll-out of its condition management programme DailyBloom™ IBS, India's first integrated care plan for Irritable Bowel Syndrome (IBS). The programme is based on extensive research and is enabled by a mobile application developed in-house. DailyBloom™ IBS focuses on a comprehensive care plan that includes diet management, psychological and physical wellness support for patients with IBS. Dr. Reddy's has launched the programme on ‘World IBS Day', a day that aims to increase awareness of the IBS condition, discuss misconceptions, challenges and even stigma attached to it.